GPCR/G protein

All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
-
B7531 WAY 208466 dihydrochlorideTarget: 5-HT6 ReceptorSummary: 5-HT6 agonist -
B7497 CP 135807Summary: 5-HT1D receptor agonist -
B7470 SGS 518 oxalateSummary: 5-HT6 antagonist -
B7437 Org 12962 hydrochlorideSummary: 5-HT2C receptor agonist -
B7413 ML 10302 hydrochlorideSummary: 5-HT4 partial agonist -
B7377 LY 393558Summary: Dual 5-HT1B/1D receptor antagonist -
B7366 BGC 20-761Summary: 5-HT6 antagonist,selective and high affinity -
B7344 NPS ALX Compound 4a dihydrochlorideSummary: 5-HT6 antagonist -
B7309 SB 399885 hydrochlorideSummary: 5-HT6 antagonist -
B7308 SB 699551Summary: 5-ht5a receptor antagonist
